4.6 Review

SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine

期刊

MOLECULAR ASPECTS OF MEDICINE
卷 34, 期 2-3, 页码 360-372

出版社

ELSEVIER
DOI: 10.1016/j.mam.2012.07.005

关键词

SLC18; Monoamines; Serotonin; Dopamine; Noradrenaline; Acetylcholine; Vesicular transporter; Synaptic vesicle

资金

  1. Swiss National Science Foundation through the National Center of Competence in Research (NCCR) TransCure, University of Bern, Switzerland
  2. National Institute of Mental Health [MH076900]
  3. National Institute of Environmental Health and Safety [ES015747, ES015457]
  4. NARSAD The Brain and Behavior Research Foundation
  5. NIEHS [ES016732]

向作者/读者索取更多资源

The exocytotic release of neurotransmitters requires active transport into synaptic vesicles and other types of secretory vesicles. Members of the SLC18 family perform this function for acetylcholine (SLC18A3, the vesicular acetylcholine transporter or VAChT) and monoamines such as dopamine and serotonin (SLC18A1 and 2, the vesicular monoamine transporters VMAT1 and 2, respectively). To date, no specific diseases have been attributed to a mutation in an SLC18 family member; however, polymorphisms in SLC18A1 and SLC18A2 may confer risk for some neuropsychiatric disorders. Additional members of this family include SLC18A4, expressed in insects, and SLC18B1, the function of which is not known. SLC18 is part of the Drug:H+ Antiporter-1 Family (DHA1, TCID 2.A.1.2) within the Major Facilitator Superfamily (MFS, TCID 2.A.1). (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据